Guaiacol

Guaiacol

SCHEMBL27872505

COc1ccccc1O.OCCO

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.82
TP53 P04637 2/20 0.82
CA1 P00915 2/20 0.82
CA2 P00918 2/20 0.82
MAPT P10636 4/20 0.58
LMNA P02545 3/20 0.58
CYP3A4 P08684 3/20 0.58
ALDH1A1 P00352 2/20 0.58
KDM4E B2RXH2 2/20 0.58
MAPK1 P28482 2/20 0.58
HPGD P15428 1/20 0.58
ALOX15 P16050 1/20 0.58
ALOX12 P18054 1/20 0.58
HSD17B10 Q99714 1/20 0.58
CA12 O43570 1/20 0.52
CA4 P22748 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
CA14 Q9ULX7 1/20 0.52
JAK2 O60674 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guaiacol SCHEMBL27509885 0.93 CA1 (0.86) TSHRTP53CA1CA2MAPT
Guaiacol SCHEMBL27482331 0.92 CA1 (0.69) TSHRTP53CA1CA2MAPT
Guaiacol SCHEMBL11570825 0.91 TP53 (0.75) TSHRTP53CA1CA2MAPT
Guaiacol SCHEMBL21626 0.91
Guaiacol SCHEMBL671733 0.91 CA2 (1.00) TSHRTP53CA1CA2MAPT
Guaiacol SCHEMBL29454477 0.91
Guaiacol SCHEMBL2033828 0.90 TP53 (0.67) TSHRTP53CA1CA2MAPT
Guaiacol SCHEMBL28330363 0.88 CA1 (0.86) TSHRTP53CA1CA2MAPT
Guaiacol SCHEMBL25403512 0.88 CA2 (0.95) TSHRTP53CA1CA2MAPT
Guaiacol SCHEMBL15553824 0.88 CA2 (0.95) TSHRTP53CA1CA2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102483416-A Means And Methods For Diagnosing Prostate Carcinomas METANOMICS HEALTH GMBH DE 2012-05-30 CN claimed
CN-102483416-A Means And Methods For Diagnosing Prostate Carcinomas METANOMICS HEALTH GMBH DE 2012-05-30 CN disclosed